Abstract
Australia — Cochlear's Inventor Professor Graeme Clark Wins Top Research Prize. Australia — Biotech Projects Receive a Solid Share of ARC Funding. Australia — Australia Commits A$25 Million to Tackle Malaria in the Pacific. Australia — Western Australia to Get A$200 Million Worth of Research Hubs. Australia — Australian Government Funds Pharmaceutical Partnerships Program. China — New Diabetic Eye Disease Center in Beijing. China — Akzo Nobel to Open Two Chemical Plants. China — China Tightens Controls on Blood-Based Medicines. China — China Donates US$8 Million to WHO. China — Establishment of Eight New State Key Labs at CAS Approved. China — SFDA Approves Second Phase Trials for Bird Flu Vaccine. Hong Kong — Asia to Test Injectable Drug for Bird and Human Flu. Japan — Japan Investigates More Flu Drugs for Inducing Abnormal Behavior. Japan — Japan and South Korea to Launch First Joint Clinical Study of Cancer Drug. India — Senate Committee Approves Bill that would Reauthorize American Indian Health Care Improvement Act. Malaysia — Malaysia Plans New Law to Regulate Genetically Modified Foods. New Zealand — New Zealand Researchers Use Bacterial Enzymes to Boost Chemotherapy. New Zealand — New Zealand Government Tests Pandemic Action Plan. Singapore — Singapore University Plans to Set up Bioengineering Research Center. Singapore — Singapore and Indonesia to Join Forces in the Battle Against Bird Flu. Singapore — Singapore to Set Up New Legal Framework to Protect Personal Data of Biomedical Research Participants. Taiwan — Pingtung Biotech Park Opens in July. Thailand — Abbott Makes New Offer of US $1 000 per Person for HIV/AIDS Drug. Vietnam — Vietnam Reports New Bird Flu Outbreak.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.